妊娠期全氟和多氟烷基物质浓度与产后健康:Project Viva前瞻性队列研究
在Project Viva前瞻性队列中,研究了1999至2002年招募的孕妇妊娠期血浆PFAS浓度与产后3年人体测量学及生物标志物的关联。调整混杂后,某些PFAS浓度与产后3年更大的肥胖程度和更高的收缩压相关,EtFOSAA浓度还与IL-6升高和SHBG降低相关。
要点
- 妊娠期EtFOSAA、PFOS和PFOA浓度与产后3年不良心血管代谢标志物相关。
- EtFOSAA每翻倍,产后3年腰围增加0.4 cm(95%CI:-0.1,0.9),IL-6升高10.8%(95%CI:3.3,18.9)。
- PFOS每翻倍,产后3年肩胛下与三头肌皮褶厚度之和增厚1.2 mm(95%CI:0.1,2.2),收缩压升高1.2 mm Hg(95%CI:0.3,2.2)。
核心结论
- 妊娠期EtFOSAA、PFOS和PFOA浓度与产后不良心血管代谢标志物相关。
研究设计与样本
- 前瞻性队列研究,纳入Project Viva队列中1999至2002年招募的孕妇,检测妊娠期血浆PFAS浓度。
- 产后3年人体测量学数据来自786至801名女性,血压数据来自761名女性,血液生物标志物数据来自450至454名女性。
- 采用多变量回归评估经log2转换的PFAS与产后人体测量学、血压和血液生物标志物的关联,并调整年龄、孕前体重指数、婚姻状况、种族/民族、教育、收入、吸烟、产次和哺乳史。
主要发现
- EtFOSAA每翻倍,产后3年腰围增加0.4 cm(95%CI:-0.1,0.9)。
- PFOA每翻倍,产后3年上臂中围增加0.2 cm(95%CI:-0.1,0.5)。
- PFOS每翻倍,产后3年肩胛下与三头肌皮褶厚度之和增厚1.2 mm(95%CI:0.1,2.2)。
- PFOS每翻倍,产后3年收缩压升高1.2 mm Hg(95%CI:0.3,2.2)。
- EtFOSAA每翻倍,产后3年IL-6升高10.8%(95%CI:3.3,18.9),SHBG降低6.1%(95%CI:0.7,11.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Per- and polyfluoroalkyl substances (PFAS) are environmental chemicals linked to weight gain and type 2 diabetes. OBJECTIVE: We examined the extent to which PFAS plasma concentrations during pregnancy were associated with postpartum anthropometry and biomarkers. DESIGN, PATIENTS, AND MEASURES: We studied women recruited between 1999 and 2002 in the Project Viva prospective cohort with pregnancy plasma concentrations of PFAS, including perfluorooctanesulfonic acid (PFOS), perfluorooctanoic acid (PFOA), and 2-(N-ethyl-perfluorooctane sulfonamide) acetic acid (EtFOSAA). Three-year postpartum anthropometry measurements were available from 786 to 801 women, blood pressure from 761 women, and blood biomarkers from 450 to 454 women. We used multivariable regression to evaluate the association of log2-transformed PFAS with postpartum anthropometry, blood pressure, and blood biomarkers (leptin, adiponectin, sex hormone binding globulin [SHBG], hemoglobin A1c, interleukin-6 [IL-6], C-reactive protein), adjusting for age, prepregnancy body mass index, marital status, race/ethnicity, education, income, smoking, parity, and breastfeeding history. RESULTS: Pregnancy concentrations of certain PFAS were associated with greater adiposity (eg, 0.4 cm [95% confidence interval [95%CI]: -0.1, 0.9] greater waist circumference per doubling in EtFOSAA; 0.2 cm [95%CI: -0.1, 0.5] greater mid-upper arm circumference per doubling in PFOA; 1.2 mm [95%CI: 0.1, 2.2] thicker sum of subscapular and triceps skinfolds per doubling in PFOS) and higher systolic blood pressure (eg, 1.2 mm Hg [95%CI: 0.3, 2.2] per doubling in PFOS) at 3 years postpartum. Higher EtFOSAA concentrations were also associated with 10.8% higher IL-6 (95%CI: 3.3, 18.9) and 6.1% lower SHBG (95%CI: 0.7, 11.2) per doubling. CONCLUSIONS: Pregnancy concentrations of EtFOSAA, PFOS, and PFOA were associated with adverse postpartum cardiometabolic markers.
引用
- Mitro SD, Sagiv SK, Fleisch AF, et al. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort. J Clin Endocrinol Metab. 2020. PMID: 32620010. doi:10.1210/clinem/dgaa431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。